HELM INTELLIGENCEMRK
Preparing your analysis.
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Working on your request
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Merck & Co., Inc. presents a mixed financial profile with both growth potential and challenges.
Merck & Co., Inc. has a market capitalization of $364.19B and is currently priced at $145.27, reflecting a decline of 1.30% from the previous close of $147.19. The company's P/E ratio stands at 19.95, with a revenue growth of 1.31% year-over-year and an EPS growth of 8.01%. Merck's dividend yield is 2.24%, and it has a current ratio of 1.54.
Some investors point to Merck's strong EPS growth of 8.01% year-over-year as a sign of robust underlying performance. Additionally, the company's high return on equity (ROE) of 34.70% suggests efficient use of equity capital.
On the bearish side, Merck's revenue growth of only 1.31% year-over-year may raise concerns about its ability to maintain momentum in a competitive pharmaceutical landscape. Furthermore, the stock's current price is significantly below its 52-week high of $156.91, potentially indicating market skepticism.
Hold MRK? See what it does to your whole book.
Connect a brokerage read-only and Helm shows MRK next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See MRK in my portfolioHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
Hold MRK? See what it does to your whole book.
Connect a brokerage read-only and Helm shows MRK next to everything you hold: how concentrated you are, what moved today, and a daily brief on all of it. Free, no card.
See MRK in my portfolioMerck & Co., Inc. has a market capitalization of $364.19B and is currently priced at $145.27, reflecting a decline of 1.30% from the previous close of $147.19. The company's P/E ratio stands at 19.95, with a revenue growth of 1.31% year-over-year and an EPS growth of 8.01%. Merck's dividend yield is 2.24%, and it has a current ratio of 1.54.
On the bearish side, Merck's revenue growth of only 1.31% year-over-year may raise concerns about its ability to maintain momentum in a competitive pharmaceutical landscape. Furthermore, the stock's current price is significantly below its 52-week high of $156.91, potentially indicating market skepticism.
Some investors point to Merck's strong EPS growth of 8.01% year-over-year as a sign of robust underlying performance. Additionally, the company's high return on equity (ROE) of 34.70% suggests efficient use of equity capital.
Some investors point to Merck's strong EPS growth of 8.01% year-over-year as a sign of robust underlying performance. Additionally, the company's high return on equity (ROE) of 34.70% suggests efficient use of equity capital. On the bearish side, Merck's revenue growth of only 1.31% year-over-year may raise concerns about its ability to maintain momentum in a competitive pharmaceutical landscape. Furthermore, the stock's current price is significantly below its 52-week high of $156.91, potentially indicating market skepticism.
Merck & Co., Inc. has a market capitalization of $364.19B and is currently priced at $145.27, reflecting a decline of 1.30% from the previous close of $147.19. The company's P/E ratio stands at 19.95, with a revenue growth of 1.31% year-over-year and an EPS growth of 8.01%. Merck's dividend yield is 2.24%, and it has a current ratio of 1.54.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for MRK at helmterminal.dev/analyze/MRK, updated continuously during US market hours. No signup required.